523 related articles for article (PubMed ID: 27172799)
1. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
Shiozawa Y; Berry JE; Eber MR; Jung Y; Yumoto K; Cackowski FC; Yoon HJ; Parsana P; Mehra R; Wang J; McGee S; Lee E; Nagrath S; Pienta KJ; Taichman RS
Oncotarget; 2016 Jul; 7(27):41217-41232. PubMed ID: 27172799
[TBL] [Abstract][Full Text] [Related]
2. Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow.
Jung Y; Decker AM; Wang J; Lee E; Kana LA; Yumoto K; Cackowski FC; Rhee J; Carmeliet P; Buttitta L; Morgan TM; Taichman RS
Oncotarget; 2016 May; 7(18):25698-711. PubMed ID: 27028863
[TBL] [Abstract][Full Text] [Related]
3. The prostate cancer bone marrow niche: more than just 'fertile soil'.
Pedersen EA; Shiozawa Y; Pienta KJ; Taichman RS
Asian J Androl; 2012 May; 14(3):423-7. PubMed ID: 22367179
[TBL] [Abstract][Full Text] [Related]
4. Parallels between hematopoietic stem cell and prostate cancer disseminated tumor cell regulation.
Cackowski FC; Taichman RS
Bone; 2019 Feb; 119():82-86. PubMed ID: 29496517
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer and parasitism of the bone hematopoietic stem cell niche.
Yu C; Shiozawa Y; Taichman RS; McCauley LK; Pienta K; Keller E
Crit Rev Eukaryot Gene Expr; 2012; 22(2):131-48. PubMed ID: 22856431
[TBL] [Abstract][Full Text] [Related]
6. Mapping bone marrow niches of disseminated tumor cells.
Zhang W; Lo HC; Zhang XH
Sci China Life Sci; 2017 Oct; 60(10):1125-1132. PubMed ID: 29027156
[TBL] [Abstract][Full Text] [Related]
7. Biochemical Changes in the Niche Following Tumor Cell Invasion.
Decker AM; Cackowski FC; Jung Y; Taichman RS
J Cell Biochem; 2017 Aug; 118(8):1956-1964. PubMed ID: 27982511
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors.
Shiozawa Y; Pienta KJ; Taichman RS
Clin Cancer Res; 2011 Sep; 17(17):5553-8. PubMed ID: 21676926
[TBL] [Abstract][Full Text] [Related]
9. Sympathetic Signaling Reactivates Quiescent Disseminated Prostate Cancer Cells in the Bone Marrow.
Decker AM; Jung Y; Cackowski FC; Yumoto K; Wang J; Taichman RS
Mol Cancer Res; 2017 Dec; 15(12):1644-1655. PubMed ID: 28814453
[TBL] [Abstract][Full Text] [Related]
10. Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow.
Shiozawa Y; Pedersen EA; Havens AM; Jung Y; Mishra A; Joseph J; Kim JK; Patel LR; Ying C; Ziegler AM; Pienta MJ; Song J; Wang J; Loberg RD; Krebsbach PH; Pienta KJ; Taichman RS
J Clin Invest; 2011 Apr; 121(4):1298-312. PubMed ID: 21436587
[TBL] [Abstract][Full Text] [Related]
11. A novel model of dormancy for bone metastatic breast cancer cells.
Marlow R; Honeth G; Lombardi S; Cariati M; Hessey S; Pipili A; Mariotti V; Buchupalli B; Foster K; Bonnet D; Grigoriadis A; Rameshwar P; Purushotham A; Tutt A; Dontu G
Cancer Res; 2013 Dec; 73(23):6886-99. PubMed ID: 24145351
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow niches in the regulation of bone metastasis.
Chen F; Han Y; Kang Y
Br J Cancer; 2021 Jun; 124(12):1912-1920. PubMed ID: 33758331
[TBL] [Abstract][Full Text] [Related]
13. Exploiting bone niches: progression of disseminated tumor cells to metastasis.
Muscarella AM; Aguirre S; Hao X; Waldvogel SM; Zhang XH
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33720051
[TBL] [Abstract][Full Text] [Related]
14. The hematopoietic stem-cell niche in health and leukemia.
Sánchez-Aguilera A; Méndez-Ferrer S
Cell Mol Life Sci; 2017 Feb; 74(4):579-590. PubMed ID: 27436341
[TBL] [Abstract][Full Text] [Related]
15. Determining Competitive Potential of Bone Metastatic Cancer Cells in the Murine Hematopoietic Stem Cell Niche.
Park SH; Eber MR; Taichman RS; Shiozawa Y
Methods Mol Biol; 2019; 2002():141-150. PubMed ID: 30099699
[TBL] [Abstract][Full Text] [Related]
16. A perivascular niche in the bone marrow hosts quiescent and proliferating tumorigenic colorectal cancer cells.
Möhrmann L; Zowada MK; Strakerjahn H; Siegl C; Kopp-Schneider A; Krunic D; Strunk D; Schneider M; Kriegsmann M; Kriegsmann K; Herbst F; Ball CR; Glimm H; Dieter SM
Int J Cancer; 2020 Jul; 147(2):519-531. PubMed ID: 32077087
[TBL] [Abstract][Full Text] [Related]
17. A new model of multi-visceral and bone metastatic prostate cancer with perivascular niche targeting by a novel endothelial specific adenoviral vector.
Lu ZH; Kaliberov S; Sohn RE; Kaliberova L; Du Y; Prior JL; Leib DJ; Chauchereau A; Sehn JK; Curiel DT; Arbeit JM
Oncotarget; 2017 Feb; 8(7):12272-12289. PubMed ID: 28103576
[TBL] [Abstract][Full Text] [Related]
18. Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.
Talukdar S; Bhoopathi P; Emdad L; Das S; Sarkar D; Fisher PB
Adv Cancer Res; 2019; 141():43-84. PubMed ID: 30691685
[TBL] [Abstract][Full Text] [Related]
19. Disseminated tumor cells and dormancy in prostate cancer metastasis.
van der Toom EE; Verdone JE; Pienta KJ
Curr Opin Biotechnol; 2016 Aug; 40():9-15. PubMed ID: 26900985
[TBL] [Abstract][Full Text] [Related]
20. Role of secreted factors in the regulation of hematopoietic stem cells by the bone marrow microenvironment.
Kaur-Bollinger P; Gotze KS; Oostendorp RA
Front Biosci (Landmark Ed); 2012 Jan; 17(3):876-91. PubMed ID: 22201779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]